Innovation Partnerships at the University of Michigan
Venture capitalAnn Arbor · Seed–Series A · 3 people tracked
Investment thesis
Michigan Biomedical Venture Fund is an investment vehicle affiliated with the University of Michigan that provides funding to early-stage companies developing therapeutics, medical devices, diagnostics, or health IT applications based on university-licensed intellectual property. The fund focuses exclusively on biomedical startups originating from U-M technology.
Team · 3 people
from public directoriesFrequently asked questions
- What stage does Innovation Partnerships at the University of Michigan invest at?
- Innovation Partnerships at the University of Michigan invests at the Seed, Series A stages.
- What is Innovation Partnerships at the University of Michigan's typical check size?
- Innovation Partnerships at the University of Michigan typically writes checks of $100K – $300K.
- What sectors does Innovation Partnerships at the University of Michigan focus on?
- Innovation Partnerships at the University of Michigan focuses on Biotech, Fintech, Healthtech, Medical Devices, Mobility & Transportation, SaaS.
- Where is Innovation Partnerships at the University of Michigan located?
- Innovation Partnerships at the University of Michigan is headquartered in Ann Arbor, US.
Similar investors
Khosla Ventures is a venture capital firm known for backing bold, contrarian bets in world-class teams that can reshape entire industries.
K3 Ventures presents itself as an investment platform focused on collaboration and partnership between founders and stakeholders, emphasizing trust, relevance, and long-term support.
Taiwania Capital is a venture capital firm investing across technology and life science sectors, backing companies in Taiwan, Europe, and globally.
Colle Capital Partners is a venture capital firm that invests across technology-driven sectors, backing companies in AI, healthcare, fintech, construction, energy and other markets globally.
Chinese venture capital firm (Hua Chuang Capital / CGC) investing since 2014, with a focus on technology and software companies. It offers both venture capital and venture lending along with value-add support.